| Company | Designation | Period |
|---|---|---|
| Rubicon Research Private Limited | Founder and Chief Operating Officer | May 1999 – Jul 2014 |
| Novartis | Formulation Development Manager | Jun 1993 – Aug 1998 |
| GSK | Pharmacist | Jun 1987 – May 1993 |
| Tata Pharma laboratories | Product Development Officer | Jun 1986 – May 1987 |
| Piramal Healthcare (formerly Nicholas Laboratories), India | Product Development Officer | Jan 1985 – May 1986 |
| Rubicon Research Private Limited | Founder and Director | Aug 2014 – Dec 2016 |
| Amaterasu Lifesciences LLP | Founder and Managing Partner | Dec 2016 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Amaterasu Lifesciences Llp corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Maharukh Rustomjee's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Amaterasu Lifesciences Llp's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)